Trials / Recruiting
RecruitingNCT07210671
Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,576 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Superficial venous thrombosis (SVT) is very common in clinical practice. What's more, around 15- 20% of SVTs occur in the context of cancer. Today, cancer patients are excluded from therapeutic trials for DVT. There is therefore no high-level evidence-based treatment recommendation for these patients. Recent data suggest that the course of cancer-associated DVT is similar to that of cancer-associated deep vein thrombosis (DVT). However, there are currently few prospective data on the evolution of cancer-associated DVT in relation to the treatment used. Due to the absence of clear recommendations of treatment in case of SVT associated with cancer the investigators will perform a prospective observational study to evaluate the efficacy of different regiment of anticoagulant treatment ordered in clinical practice.
Conditions
Timeline
- Start date
- 2025-11-10
- Primary completion
- 2027-11-01
- Completion
- 2028-11-01
- First posted
- 2025-10-07
- Last updated
- 2026-04-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07210671. Inclusion in this directory is not an endorsement.